Cardiol therapeutics to webcast virtual annual general meeting of shareholders on may 28th at 4:30 p.m. edt

Toronto, ontario--(newsfile corp. - may 27, 2025) - cardiol therapeutics inc. (nasdaq: crdl) (tsx: crdl) ("cardiol" or the "company"), a clinical-stage life sciences company focused on developing anti-inflammatory and anti-fibrotic therapies for the treatment of heart disease, announces that the company's virtual annual general meeting of shareholders (the "agm") will be webcast on may 28, 2025, at 4:30 p.m. edt. cardiol therapeutics' 2025 agm when: may 28, 2025, at 4:30 p.m.
GM Ratings Summary
GM Quant Ranking